LigaChem Biosciences Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	7,287,910	6,323,571	3,975,267	1,827,289	1,092,804	1,352,308
Market Cap Growth	111.66%	59.07%	117.55%	67.21%	-19.19%	138.87%
Enterprise Value	6,849,618	5,787,020	3,458,030	1,723,146	929,358	1,262,535
Last Close Price	200000.00	173700.00	109000.00	65000.00	42850.00	55800.00
PE Ratio	-	-	509.64	-	-	-
Forward PE	-	44.50	44.50	44.50	44.50	44.50
PS Ratio	51.49	44.67	31.58	53.52	32.71	42.05
PB Ratio	13.47	11.69	6.45	12.33	4.98	5.23
P/TBV Ratio	18.08	15.69	6.54	12.94	5.19	5.44
P/FCF Ratio	-	-	52.41	-	-	-
P/OCF Ratio	-	-	50.66	-	-	-
EV/Sales Ratio	48.39	40.88	27.47	50.47	27.82	39.26
EV/FCF Ratio	-53.69	-	45.59	-	-	-
Debt / Equity Ratio	0.01	0.01	0.00	0.09	0.06	0.05
Debt / FCF Ratio	-	-	0.01	-	-	-
Net Debt / Equity Ratio	-0.87	-0.87	-0.80	-0.59	-0.72	-0.65
Net Debt / EBITDA Ratio	4.72	4.72	31.01	1.15	3.41	6.84
Net Debt / FCF Ratio	3.70	3.70	-6.50	1.37	13.96	2.79
Asset Turnover	0.20	0.20	0.27	0.15	0.12	-
Inventory Turnover	96.48	96.48	77.94	82.64	66.32	-
Quick Ratio	8.20	8.20	4.46	3.21	6.61	13.35
Current Ratio	8.54	8.54	4.70	3.63	6.70	13.45
Return on Equity (ROE)	-15.82%	-15.82%	2.04%	-40.08%	-18.85%	-
Return on Assets (ROA)	-9.24%	-9.24%	-2.82%	-22.86%	-11.54%	-
Return on Invested Capital (ROIC)	-245.76%	-110.81%	-19.45%	-131.59%	-66.23%	-48.80%
Return on Capital Employed (ROCE)	-16.60%	-16.60%	-3.40%	-53.00%	-22.50%	-10.00%
Earnings Yield	-1.02%	-1.18%	0.20%	-4.03%	-4.13%	-1.73%
FCF Yield	-1.75%	-2.02%	1.91%	-3.48%	-1.03%	-4.46%
Buyback Yield / Dilution	-4.68%	-4.68%	-22.36%	-1.38%	-16.13%	-0.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.